ARC
SPPI

Absolute Return Capital’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Absolute Return Capital’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-24,843
Closed -$202K – 1000
2014
Q2 		$202K Buy
+24,843
New +$188K ﹤0.01% 1017

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Absolute Return Capital's SPPI Position: Q3 2014 in Review

Absolute Return Capital sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2014, closing a stake of 24,843 shares — an estimated $202K sold.

Absolute Return Capital first reported a position in SPPI in Q2 2014 and held it in 1 quarter. The position peaked at $202K in Q2 2014. 127 funds tracked by Wall St. Rank hold SPPI as of Q3 2014.

  • Absolute Return Capital reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2014 after selling out during the quarter.
  • Absolute Return Capital sold 24,843 Spectrum Pharmaceuticals Inc shares in Q3 2014, an estimated $202K.
  • Absolute Return Capital first reported a position in Spectrum Pharmaceuticals Inc in Q2 2014 and held it in 1 quarter.
  • Absolute Return Capital's Spectrum Pharmaceuticals Inc position peaked at $202K in Q2 2014.
  • 127 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2014.

Based on Absolute Return Capital's 13F filing for Q3 2014, filed 14 Nov 2014.